Sun Pharma to Acquire Checkpoint Therapeutics ...Middle East

Will add UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise Will leverage Sun Pharma's global presence to accelerate patient access to...

Read More Details
Finally We wish PressBee provided you with enough information of ( Sun Pharma to Acquire Checkpoint Therapeutics )

Also on site :

• Mariska Hargitay Reveals the Identity of Her Biological Father
• Andrea Fuder, Chief Purchasing Officer at Volvo Group has tragically passed away
• Romania holds runoff vote in presidential election rerun